Monash University

Consistently ranking in the top 40 universities worldwide for clinical, pre-clinical and health sciences, Monash University boasts one of Australia’s best and most integrative neuroscience research programs through its Faculties of Medicine, Nursing and Health Sciences, Pharmacy, Engineering, Science, Art and Design, as well as the major Monash affiliated teaching hospitals.

The University’s multidisciplinary approach to translational research expedites discovery and innovation by also collaborating with co-located research organisations such as the Commonwealth Scientific and Industrial Research Organisation (CSIRO), the Australian Synchrotron, Monash Medical Centre, Melbourne Centre for Nanofabrication (MCN), Australian Regenerative Medicine Institute (ARMI), Hudson Institute for Medical Research and the Monash Health Translation Precinct (MHTP).

Key Areas of Research

Monash University performs leading edge research and clinical investigation in key areas of neuroscience and mental health. The University’s commitment to research is performed amongst a number of our faculties, schools, institutes, centres and collaborating organisations.

Major areas of research include:

  • Neuroimaging
  • Neuroinflammation
  • Developmental neuroscience
  • Developmental brain injury
  • Regenerative medicine
  • Ageing and neurodegeneration
  • Brain plasticity and repair
  • Huntington’s disease
  • Cognition
  • Control of movement and emotions
  • Anxiety disorders
  • Addiction and compulsive behaviour
  • Alzheimer’s disease
  • Stroke
  • Sensory physiology
  • Schizophrenia
  • Depression
  • Autism
  • Attention deficit hyperactivity disorder
  • Traumatic brain injury
  • Bipolar affective disorder
  • Intellectual disability
  • Metabolic neuroscience

Major Research Groups

The School of Psychological Sciences is home to a number of research centres and institutes. These have comprehensive research programs in addiction, brain injury and rehabilitation, memory and consciousness, neurodegeneration, neurodevelopment, psychopathology: prevention and intervention and sleep.

The Monash Alfred Psychiatry Research Centre (MAPrc) is one of Australia’s largest clinical research centres in psychiatry, conducts world-class research to improve the lives of people suffering from serious mental illnesses.

The Monash Institute of Cognitive and Clinical Neurosciences aims to improve the understanding of the human brain through innovative research approaches. It is the largest institute of its kind in Australia and the largest grouping of cognitive and clinical neuroscientists in the Asia-Pacific region.

The Neuroscience and Neurology Research Group at Monash Health conducts a broad spectrum of research from clinical to laboratory science. Research expertise includes stroke and ageing, movement disorders and epilepsy.

The Monash Biomedical Imaging (MBI) Facility provides a full suite of world-class biomedical imaging equipment and expertise for preclinical and clinical research. MBI’s cognitive neuroimaging team provides support for all human research studies.

The Hudson Institute of Medical Research is home to six specialist research centres which include the Ritchie Centre’s Neurodevelopment and Neuroprotection group and the Centre for Cancer Research Brain Cancer Discovery Collaborative (BCDC), where Australia’s leading brain cancer researchers and doctors are working together to extend patients’ lives.

The Monash Institute for Medical Engineering (MIME) currently runs three research themes including Neuroscience and Vision. Here, the Monash Vision Group (MVG) is working with Grey Innovation and MiniFab to develop the first Direct to Brain Bionic Vision device (Gennaris) for those afflicted with acquired blindness. This is a multi-electrode prosthesis for implantation into the visual cortex of the brain.

The Monash Biomedicine Discovery Institute (BDI) Neuroscience Program comprises 14 primary group leaders and their research teams. Together, they bring expertise from across the spectrum of neuroscience research from cellular and systems neuroscience, through to identifying and testing new treatment options. A further 16 group leaders from other BDI programs are linked to the Neuroscience Program as associates.

Major Technology Platforms

  • Structural biology/Cryo EM/high-throughput protein production
  • Genomics, bioinformatics and proteomics
  • Optical imaging
  • Monoclonal antibody production (MATF)
  • Mouse phenomics/transgenics
  • Biomedical imaging and image processing
  • Image driven High Performance Computing (MASSIVE)
  • Fragment Based Drug Design and development
  • Biostatistics, data-management and bio-banking
  • Engineering (additive manufacturing, X-Ray diffraction etc)
  • Material sciences
  • Nanofabrication (MCN)
  • Drug discovery, medicinal chemistry, drug candidate optimisation
  • Clinical trials

BrainPark™ Platform Facility Commits to Compulsive Disorders

Following an initial $5.25m gift towards mental health research at Monash University, the David Winston Turner Endowment Fund continued its commitment to clinical translation of research outcomes by joining forces with Monash University, announcing a further $3.2m funding to establish BrainPark™, a cutting-edge clinical research platform at the Monash Institute of Cognitive and Clinical Neurosciences (MICCN).

Led by Professor Murat Yücel, BrainPark™ will be the world’s first research facility to offer lifestyle and technology-based interventions for compulsive disorders, including addictions and Obsessive-compulsive Disorder (OCD).

Professor Yücel and his team have built a comprehensive program utilising virtual-reality based immersive environments for researching and treating OCD. The program is also researching novel brain stimulation, brain training and lifestyle-based interventions for people who experience compulsions.

A key differentiating aspect of BrainPark™ is the radical departure from the traditional research lab and clinical treatment environment. People who come to BrainPark™ will be immersed in an interactive, creative and energising environment, removing many of the traditional barriers to engagement for participants in clinical interventions.

As the platform grows, Monash University will be looking to extend beyond addiction and compulsive disorders, with the potential to explore other neurological and medical conditions.

Monash University’s BrainPark™ facility will be launched and ready for operation in mid-2018.

Monash at a Glance

  • Monash is Australia’s most internationalised university.
  • Monash has more than 70,000 students from over 100 countries.
  • Monash is a member of the prestigious Group of Eight (Go8) universities, recognised for excellence in teaching, learning, research and graduate outcomes.
  • Monash has eight campuses: six in Australia, one in Malaysia, one in South Africa and a centre in Prato, Italy.
  • Monash has formed strong strategic partnerships in the UK (Warwick and Newcastle Universities), China (South East University, Suzhou) India (Indian Institute of Technology Bombay, Mumbai) and Germany (Fruanhofer Institute for Cell Therapy and Immunology).